<DOC>
	<DOCNO>NCT00553930</DOCNO>
	<brief_summary>Hypothesis : A regimen low dose peginterferon alfa-2a plus ribavirin may effective currently recommend regimen chronic hepatitis C HIV-coinfected patient . Objective : To evaluate efficacy low dose pegylated interferon-α 2a ( 135 µg weekly ) plus ribavirin short duration treatment ( 20 week achieve undetectable plasmatic HCV-RNA ) current recommend patient chronic hepatitis compensate cirrhosis hepatitis C virus , genotypes 2 3 , HIV-coinfected patient real use condition . Method : Phase IV , postautorization , open label multicenter trial plan duration 118 week 71 patient several hospital Servicio Andaluz de Salud enrol . The usual clinical analytical follow perform additional blood sample obtain determination interferon ribavirin plasma level . The primary end point wall sustain virologic response ( define undetectable serum HCV-RNA 24 week cessation treatment ) . Likewise , rapid virological response ( 4 week treatment ) , early virological response ( 12 week ) , end treatment response rate evaluate well relationship plasma interferon ribavirin concentration determine ELISA HPLC , respectively . The safety tolerability study medication evaluate mean clinical adverse event , physical examination laboratory result .</brief_summary>
	<brief_title>Low Dose Peginterferon-α 2a Chronic Hepatitis C , Genotypes 2 3 , HIV-coinfected Patients</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Age old 18 year HIV infect , diagnose chronic hepatitis compensate cirrhosis hepatitis C virus ( antiHCV antibody HCV RNA level detectable serum ) previously treat . Women childbearing age : negative pregnancy test Ability understand sign write consent form Previous interferon treatment Pregnancy breastfeed Acute chronic hepatitis B infection ( positivity hepatitis B surface antigen plasma DNA ) Creatinine clearance &lt; 50 ml/min , accord CockcroftGault Decompensated liver disease History organ transplantation Concomitant treatment immunomodulators didanosine Alcohol abuse use recreational drug History severe psychiatric condition Autoimmune disease Inability understand sign write consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>HCV/HIV-coinfected patient</keyword>
	<keyword>Peginterferon alfa-2a</keyword>
</DOC>